Eugene Kennedy
Director Técnico/Científico/I+D en CARISMA THERAPEUTICS, INC. .
Fortuna: - $ al 30/04/2024
Perfil
Eugene P.
Kennedy is currently the Chief Medical Officer at Carisma Therapeutics, Inc. He previously held positions as an Associate Professor-Surgery at Thomas Jefferson University from 2006 to 2013, Vice President-Clinical & Medical Affairs at NewLink Genetics Corp.
from 2014 to 2017, and Chief Medical Officer at Lumos Pharma, Inc. from 2013 to 2021.
He also served as a Trustee at The Hope Funds for Cancer Research.
Additionally, he was the Chief Medical Officer at Innovative Cellular Therapeutics, Inc. and Galera Therapeutics, Inc. from 2022 to 2023.
Dr. Kennedy obtained his undergraduate degree from the University of Virginia and his doctorate from the Medical College of Virginia.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 25/02/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Cargos activos de Eugene Kennedy
| Empresas | Cargo | Inicio |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 02/05/2024 |
Antiguos cargos conocidos de Eugene Kennedy.
| Empresas | Cargo | Fin |
|---|---|---|
| GALERA THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/09/2023 |
| LUMOS PHARMA, INC. | Director Técnico/Científico/I+D | 06/03/2021 |
| Thomas Jefferson University | Corporate Officer/Principal | 01/12/2013 |
| Innovative Cellular Therapeutics, Inc. | Director Técnico/Científico/I+D | - |
The Hope Funds for Cancer Research
 The Hope Funds for Cancer Research Miscellaneous Commercial ServicesCommercial Services The Hope Funds for Cancer Research provides funds for cancer research. The private company is based in Newport, RI. The company was founded by Leah Rush Cann. | Director/Miembro de la Junta | - |
Formación de Eugene Kennedy.
| University of Virginia | Undergraduate Degree |
| Medical College of Virginia | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| LUMOS PHARMA, INC. | Health Technology |
| GALERA THERAPEUTICS, INC. | Health Technology |
| CARISMA THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. It products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189, and IDO Pathway Inhibitors. The company was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA. | Health Technology |
The Hope Funds for Cancer Research
The Hope Funds for Cancer Research Miscellaneous Commercial ServicesCommercial Services The Hope Funds for Cancer Research provides funds for cancer research. The private company is based in Newport, RI. The company was founded by Leah Rush Cann. | Commercial Services |
| Innovative Cellular Therapeutics, Inc. |
- Bolsa de valores
- Insiders
- Eugene Kennedy
